Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Sep;35(9):1697–1704. doi: 10.1128/aac.35.9.1697

More extended-spectrum beta-lactamases.

G A Jacoby 1, A A Medeiros 1
PMCID: PMC245253  PMID: 1952834

Full text

PDF
1697

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arlet G., Sanson-le Pors M. J., Rouveau M., Fournier G., Marie O., Schlemmer B., Philippon A. Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 beta-lactamase. Eur J Clin Microbiol Infect Dis. 1990 Nov;9(11):797–803. doi: 10.1007/BF01967377. [DOI] [PubMed] [Google Scholar]
  2. Barthélémy M., Peduzzi J., Labia R. Complete amino acid sequence of p453-plasmid-mediated PIT-2 beta-lactamase (SHV-1). Biochem J. 1988 Apr 1;251(1):73–79. doi: 10.1042/bj2510073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barthélémy M., Peduzzi J., Labia R. Distinction entre les structures primaires des beta-lactamases TEM-1 et TEM-2. Ann Inst Pasteur Microbiol. 1985 May-Jun;136A(3):311–321. doi: 10.1016/s0769-2609(85)80093-4. [DOI] [PubMed] [Google Scholar]
  4. Barthélémy M., Péduzzi J., Ben Yaghlane H., Labia R. Single amino acid substitution between SHV-1 beta-lactamase and cefotaxime-hydrolyzing SHV-2 enzyme. FEBS Lett. 1988 Apr 11;231(1):217–220. doi: 10.1016/0014-5793(88)80734-8. [DOI] [PubMed] [Google Scholar]
  5. Bauernfeind A., Chong Y., Schweighart S. Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection. 1989 Sep-Oct;17(5):316–321. doi: 10.1007/BF01650718. [DOI] [PubMed] [Google Scholar]
  6. Bauernfeind A., Grimm H., Schweighart S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection. 1990 Sep-Oct;18(5):294–298. doi: 10.1007/BF01647010. [DOI] [PubMed] [Google Scholar]
  7. Bauernfeind A., Hörl G. Novel R-factor borne beta-lactamase of Escherichia coli confering resistance to cephalosporins. Infection. 1987 Jul-Aug;15(4):257–259. doi: 10.1007/BF01644127. [DOI] [PubMed] [Google Scholar]
  8. Bauernfeind A. Perspectives of beta-lactamases inhibitors in therapy of infections caused by Escherichia coli or Klebsiella with plasmidic resistance to third generation cephalosporins. Infection. 1990 Jan-Feb;18(1):48–52. doi: 10.1007/BF01644185. [DOI] [PubMed] [Google Scholar]
  9. Ben Redjeb S., Fournier G., Mabilat C., Ben Hassen A., Philippon A. Two novel transferable extended-spectrum beta-lactamases from Klebsiella pneumoniae in Tunisia. FEMS Microbiol Lett. 1990 Jan 15;55(1-2):33–38. doi: 10.1016/0378-1097(90)90163-k. [DOI] [PubMed] [Google Scholar]
  10. Billot-Klein D., Gutmann L., Collatz E. Nucleotide sequence of the SHV-5 beta-lactamase gene of a Klebsiella pneumoniae plasmid. Antimicrob Agents Chemother. 1990 Dec;34(12):2439–2441. doi: 10.1128/aac.34.12.2439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Brun-Buisson C., Legrand P., Philippon A., Montravers F., Ansquer M., Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet. 1987 Aug 8;2(8554):302–306. doi: 10.1016/s0140-6736(87)90891-9. [DOI] [PubMed] [Google Scholar]
  12. Buré A., Legrand P., Arlet G., Jarlier V., Paul G., Philippon A. Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):780–782. doi: 10.1007/BF01975048. [DOI] [PubMed] [Google Scholar]
  13. Bush K., Singer S. B. Biochemical characteristics of extended broad spectrum beta-lactamases. Infection. 1989 Nov-Dec;17(6):429–433. doi: 10.1007/BF01645566. [DOI] [PubMed] [Google Scholar]
  14. Caron F., Gutmann L., Bure A., Pangon B., Vallois J. M., Pechinot A., Carbon C. Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase. Antimicrob Agents Chemother. 1990 Nov;34(11):2070–2074. doi: 10.1128/aac.34.11.2070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Casellas J. M., Goldberg M. Incidence of strains producing extended spectrum beta-lactamases in Argentina. Infection. 1989 Nov-Dec;17(6):434–436. doi: 10.1007/BF01645567. [DOI] [PubMed] [Google Scholar]
  16. Chanal C. M., Sirot D. L., Petit A., Labia R., Morand A., Sirot J. L., Cluzel R. A. Multiplicity of TEM-derived beta-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmids. Antimicrob Agents Chemother. 1989 Nov;33(11):1915–1920. doi: 10.1128/aac.33.11.1915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Christensen H., Martin M. T., Waley S. G. Beta-lactamases as fully efficient enzymes. Determination of all the rate constants in the acyl-enzyme mechanism. Biochem J. 1990 Mar 15;266(3):853–861. [PMC free article] [PubMed] [Google Scholar]
  18. Collatz E., Tran Van Nhieu G., Billot-Klein D., Williamson R., Gutmann L. Substitution of serine for arginine in position 162 of TEM-type beta-lactamases extends the substrate profile of mutant enzymes, TEM-7 and TEM-101, to ceftazidime and aztreonam. Gene. 1989 May 30;78(2):349–354. doi: 10.1016/0378-1119(89)90237-0. [DOI] [PubMed] [Google Scholar]
  19. Datta N., Kontomichalou P. Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae. Nature. 1965 Oct 16;208(5007):239–241. doi: 10.1038/208239a0. [DOI] [PubMed] [Google Scholar]
  20. Fantin B., Pangon B., Potel G., Caron F., Vallée E., Vallois J. M., Mohler J., Buré A., Philippon A., Carbon C. Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase. Antimicrob Agents Chemother. 1990 Apr;34(4):581–586. doi: 10.1128/aac.34.4.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Garbarg-Chenon A., Godard V., Labia R., Nicolas J. C. Nucleotide sequence of SHV-2 beta-lactamase gene. Antimicrob Agents Chemother. 1990 Jul;34(7):1444–1446. doi: 10.1128/aac.34.7.1444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gutmann L., Ferré B., Goldstein F. W., Rizk N., Pinto-Schuster E., Acar J. F., Collatz E. SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob Agents Chemother. 1989 Jun;33(6):951–956. doi: 10.1128/aac.33.6.951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gutmann L., Kitzis M. D., Billot-Klein D., Goldstein F., Tran Van Nhieu G., Lu T., Carlet J., Collatz E., Williamson R. Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam. Rev Infect Dis. 1988 Jul-Aug;10(4):860–866. doi: 10.1093/clinids/10.4.860. [DOI] [PubMed] [Google Scholar]
  24. Herzberg O., Moult J. Bacterial resistance to beta-lactam antibiotics: crystal structure of beta-lactamase from Staphylococcus aureus PC1 at 2.5 A resolution. Science. 1987 May 8;236(4802):694–701. doi: 10.1126/science.3107125. [DOI] [PubMed] [Google Scholar]
  25. Huletsky A., Couture F., Levesque R. C. Nucleotide sequence and phylogeny of SHV-2 beta-lactamase. Antimicrob Agents Chemother. 1990 Sep;34(9):1725–1732. doi: 10.1128/aac.34.9.1725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Jacoby G. A., Carreras I. Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1990 May;34(5):858–862. doi: 10.1128/aac.34.5.858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Jacoby G. A., Medeiros A. A., O'Brien T. F., Pinto M. E., Jiang H. Broad-spectrum, transmissible beta-lactamases. N Engl J Med. 1988 Sep 15;319(11):723–724. doi: 10.1056/NEJM198809153191114. [DOI] [PubMed] [Google Scholar]
  28. Jacoby G. A., Sutton L. Properties of plasmids responsible for production of extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1991 Jan;35(1):164–169. doi: 10.1128/aac.35.1.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kitzis M. D., Liassine N., Ferré B., Gutmann L., Acar J. F., Goldstein F. In vitro activities of 15 oral beta-lactams against Klebsiella pneumoniae harboring new extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1990 Sep;34(9):1783–1786. doi: 10.1128/aac.34.9.1783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kliebe C., Nies B. A., Meyer J. F., Tolxdorff-Neutzling R. M., Wiedemann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1985 Aug;28(2):302–307. doi: 10.1128/aac.28.2.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Labia R., Morand A., Tiwari K., Sirot J., Sirot D., Petit A. Interactions of new plasmid-mediated beta-lactamases with third-generation cephalosporins. Rev Infect Dis. 1988 Jul-Aug;10(4):885–891. doi: 10.1093/clinids/10.4.885. [DOI] [PubMed] [Google Scholar]
  32. Lee K. Y., Hopkins J. D., Syvanen M. Direct involvement of IS26 in an antibiotic resistance operon. J Bacteriol. 1990 Jun;172(6):3229–3236. doi: 10.1128/jb.172.6.3229-3236.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lowbury E. J., Lilly H. A., Kidson A., Ayliffe G. A., Jones R. J. Sensitivity of Pseudomonas aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin. Lancet. 1969 Aug 30;2(7618):448–452. doi: 10.1016/s0140-6736(69)90163-9. [DOI] [PubMed] [Google Scholar]
  34. Mabilat C., Courvalin P. Development of "oligotyping" for characterization and molecular epidemiology of TEM beta-lactamases in members of the family Enterobacteriaceae. Antimicrob Agents Chemother. 1990 Nov;34(11):2210–2216. doi: 10.1128/aac.34.11.2210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Matsumoto Y., Ikeda F., Kamimura T., Yokota Y., Mine Y. Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins. Antimicrob Agents Chemother. 1988 Aug;32(8):1243–1246. doi: 10.1128/aac.32.8.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Matthew M., Hedges R. W., Smith J. T. Types of beta-lactamase determined by plasmids in gram-negative bacteria. J Bacteriol. 1979 Jun;138(3):657–662. doi: 10.1128/jb.138.3.657-662.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Mercier J., Levesque R. C. Cloning of SHV-2, OHIO-1, and OXA-6 beta-lactamases and cloning and sequencing of SHV-1 beta-lactamase. Antimicrob Agents Chemother. 1990 Aug;34(8):1577–1583. doi: 10.1128/aac.34.8.1577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Nicolas M. H., Jarlier V., Honore N., Philippon A., Cole S. T. Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother. 1989 Dec;33(12):2096–2100. doi: 10.1128/aac.33.12.2096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Pangon B., Bizet C., Buré A., Pichon F., Philippon A., Regnier B., Gutmann L. In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase. J Infect Dis. 1989 May;159(5):1005–1006. doi: 10.1093/infdis/159.5.1005. [DOI] [PubMed] [Google Scholar]
  40. Papanicolaou G. A., Medeiros A. A. Discrimination of extended-spectrum beta-lactamases by a novel nitrocefin competition assay. Antimicrob Agents Chemother. 1990 Nov;34(11):2184–2192. doi: 10.1128/aac.34.11.2184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Papanicolaou G. A., Medeiros A. A., Jacoby G. A. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother. 1990 Nov;34(11):2200–2209. doi: 10.1128/aac.34.11.2200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Paul G. C., Gerbaud G., Bure A., Philippon A. M., Pangon B., Courvalin P. TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother. 1989 Nov;33(11):1958–1963. doi: 10.1128/aac.33.11.1958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Payne D. J., Amyes S. G. Transferable resistance to extended-spectrum beta-lactams: a major threat or a minor inconvenience? J Antimicrob Chemother. 1991 Mar;27(3):255–261. doi: 10.1093/jac/27.3.255. [DOI] [PubMed] [Google Scholar]
  44. Payne D. J., Blakemore P. H., Drabu Y. J., Amyes S. G. Comparison of TEM-E3 and TEM-5 beta-lactamases. J Antimicrob Chemother. 1989 Oct;24(4):615–617. doi: 10.1093/jac/24.4.615. [DOI] [PubMed] [Google Scholar]
  45. Payne D. J., Hood J., Marriott M. S., Amyes S. G. Separation of plasmid-mediated extended spectrum beta-lactamases by fast protein liquid chromatography (FPLC system). FEMS Microbiol Lett. 1990 Jun 1;57(3):195–200. doi: 10.1016/0378-1097(90)90064-w. [DOI] [PubMed] [Google Scholar]
  46. Payne D. J., Marriott M. S., Amyes S. G. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2. J Med Microbiol. 1990 Jun;32(2):131–134. doi: 10.1099/00222615-32-2-131. [DOI] [PubMed] [Google Scholar]
  47. Payne D. J., Marriott M. S., Amyes S. G. TEM-E1: a novel beta-lactamase conferring resistance to ceftazidime. FEMS Microbiol Lett. 1989 May;50(1-2):97–100. doi: 10.1016/0378-1097(89)90466-7. [DOI] [PubMed] [Google Scholar]
  48. Petit A., Gerbaud G., Sirot D., Courvalin P., Sirot J. Molecular epidemiology of TEM-3 (CTX-1) beta-lactamase. Antimicrob Agents Chemother. 1990 Feb;34(2):219–224. doi: 10.1128/aac.34.2.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Petit A., Sirot D. L., Chanal C. M., Sirot J. L., Labia R., Gerbaud G., Cluzel R. A. Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1988 May;32(5):626–630. doi: 10.1128/aac.32.5.626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Philippon A., Ben Redjeb S., Fournier G., Ben Hassen A. Epidemiology of extended spectrum beta-lactamases. Infection. 1989 Sep-Oct;17(5):347–354. doi: 10.1007/BF01650727. [DOI] [PubMed] [Google Scholar]
  51. Philippon A., Labia R., Jacoby G. Extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1989 Aug;33(8):1131–1136. doi: 10.1128/aac.33.8.1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Philippon A., Paul G., Vedel G., Nevot P. Résistance plasmidique aux céphalosporines de 3e génération. Presse Med. 1988 Oct 26;17(37):1883–1889. [PubMed] [Google Scholar]
  53. Podbielski A., Melzer B. Nucleotide sequence of the gene encoding the SHV-2 beta-lactamase (blaSHV-2) of Klebsiella ozaenae. Nucleic Acids Res. 1990 Aug 25;18(16):4916–4916. doi: 10.1093/nar/18.16.4916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Péduzzi J., Barthélémy M., Tiwari K., Mattioni D., Labia R. Structural features related to hydrolytic activity against ceftazidime of plasmid-mediated SHV-type CAZ-5 beta-lactamase. Antimicrob Agents Chemother. 1989 Dec;33(12):2160–2163. doi: 10.1128/aac.33.12.2160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Quinn J. P., Miyashiro D., Sahm D., Flamm R., Bush K. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother. 1989 Sep;33(9):1451–1456. doi: 10.1128/aac.33.9.1451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Rice L. B., Willey S. H., Papanicolaou G. A., Medeiros A. A., Eliopoulos G. M., Moellering R. C., Jr, Jacoby G. A. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother. 1990 Nov;34(11):2193–2199. doi: 10.1128/aac.34.11.2193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Rice L. B., Yao J. D., Klimm K., Eliopoulos G. M., Moellering R. C., Jr Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model. Antimicrob Agents Chemother. 1991 Jun;35(6):1243–1244. doi: 10.1128/aac.35.6.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Sanders C. C. Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics. Annu Rev Microbiol. 1987;41:573–593. doi: 10.1146/annurev.mi.41.100187.003041. [DOI] [PubMed] [Google Scholar]
  59. Shannon K. P., King A., Phillips I., Nicolas M. H., Philippon A. Importance of organisms producing broad-spectrum SHV-group beta-lactamases into the United Kingdom. J Antimicrob Chemother. 1990 Mar;25(3):343–351. doi: 10.1093/jac/25.3.343. [DOI] [PubMed] [Google Scholar]
  60. Sirot D., Chanal C., Labia R., Meyran M., Sirot J., Cluzel R. Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniae. J Antimicrob Chemother. 1989 Oct;24(4):509–521. doi: 10.1093/jac/24.4.509. [DOI] [PubMed] [Google Scholar]
  61. Sirot D., Sirot J., Labia R., Morand A., Courvalin P., Darfeuille-Michaud A., Perroux R., Cluzel R. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. J Antimicrob Chemother. 1987 Sep;20(3):323–334. doi: 10.1093/jac/20.3.323. [DOI] [PubMed] [Google Scholar]
  62. Smith C. E., Tillman B. S., Howell A. W., Longfield R. N., Jorgensen J. H. Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase. Antimicrob Agents Chemother. 1990 Jun;34(6):1290–1293. doi: 10.1128/aac.34.6.1290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Sougakoff W., Petit A., Goussard S., Sirot D., Bure A., Courvalin P. Characterization of the plasmid genes blaT-4 and blaT-5 which encode the broad-spectrum beta-lactamases TEM-4 and TEM-5 in enterobacteriaceae. Gene. 1989 May 30;78(2):339–348. doi: 10.1016/0378-1119(89)90236-9. [DOI] [PubMed] [Google Scholar]
  64. Sowek J. A., Singer S. B., Ohringer S., Malley M. F., Dougherty T. J., Gougoutas J. Z., Bush K. Substitution of lysine at position 104 or 240 of TEM-1pTZ18R beta-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam. Biochemistry. 1991 Apr 2;30(13):3179–3188. doi: 10.1021/bi00227a004. [DOI] [PubMed] [Google Scholar]
  65. Spencer R. C., Wheat P. F., Winstanley T. G., Cox D. M., Plested S. J. Novel beta-lactamase in a clinical isolate of Klebsiella pneumoniae conferring unusual resistance to beta-lactam antibiotics. J Antimicrob Chemother. 1987 Dec;20(6):919–921. doi: 10.1093/jac/20.6.919. [DOI] [PubMed] [Google Scholar]
  66. Sutcliffe J. G. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3737–3741. doi: 10.1073/pnas.75.8.3737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Thomson K. S., Sanders C. C., Washington J. A., 2nd High-level resistance to cefotaxime and ceftazidime in Klebsiella pneumoniae isolates from Cleveland, Ohio. Antimicrob Agents Chemother. 1991 May;35(5):1001–1003. doi: 10.1128/aac.35.5.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Vatopoulos A. C., Philippon A., Tzouvelekis L. S., Komninou Z., Legakis N. J. Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J Antimicrob Chemother. 1990 Nov;26(5):635–648. doi: 10.1093/jac/26.5.635. [DOI] [PubMed] [Google Scholar]
  69. Vuye A., Verschraegen G., Claeys G. Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime. Antimicrob Agents Chemother. 1989 May;33(5):757–761. doi: 10.1128/aac.33.5.757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Watanabe M., Iyobe S., Inoue M., Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1991 Jan;35(1):147–151. doi: 10.1128/aac.35.1.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Weber D. A., Sanders C. C., Bakken J. S., Quinn J. P. A novel chromosomal TEM derivative and alterations in outer membrane proteins together mediate selective ceftazidime resistance in Escherichia coli. J Infect Dis. 1990 Aug;162(2):460–465. doi: 10.1093/infdis/162.2.460. [DOI] [PubMed] [Google Scholar]
  72. Woodford N., Payne D. J., Johnson A. P., Weinbren M. J., Perinpanayagam R. M., George R. C., Cookson B. D., Amyes S. G. Transferable cephalosporin resistance not inhibited by clavulanate in Escherichia coli. Lancet. 1990 Jul 28;336(8709):253–253. doi: 10.1016/0140-6736(90)91784-8. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES